HSBC Invests in Visible Alpha

Visible Alpha is launching a research advisory board to guide its products and services development.

research-researching-books-eyeglasses
Getty Images

HSBC invested an undisclosed amount in Visible Alpha as part of a funding round in January. The company previously raised $38 million from Goldman Sachs, Banco Santander, Exane, BNP Paribas, Macquarie Group, Royal Bank of Canada and Wells Fargo. Other investors in the firm include Bank of America, Citi, Jefferies, Morgan Stanley, and UBS.

Visible Alpha will use the investment for its growth initiatives and meet research valuation and budgeting requirements under the Markets in Financial

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Europe is counting its vendors—and souring on US tech

Under DORA, every financial company with business in the EU must report use of their critical vendors. Deadlines vary, but the message doesn’t: The EU is taking stock of technology dependencies, especially upon US providers.

The European T+1 effect on Asia

T+1 is coming in Europe, and Asian firms should assess impacts and begin preparations now, says the DTCC’s Val Wotton.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here